PMC:7102662 / 17810-17988 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T160","span":{"begin":115,"end":118},"obj":"Disease"},{"id":"T161","span":{"begin":161,"end":169},"obj":"Disease"}],"attributes":[{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0012733"},{"id":"A161","pred":"mondo_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T29","span":{"begin":110,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"}],"text":"Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T147","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T285","span":{"begin":161,"end":169},"obj":"SP_7"},{"id":"T85605","span":{"begin":96,"end":104},"obj":"SP_7"},{"id":"T327","span":{"begin":161,"end":169},"obj":"SP_7"}],"text":"Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"504","span":{"begin":144,"end":151},"obj":"Species"},{"id":"507","span":{"begin":161,"end":169},"obj":"Disease"}],"attributes":[{"id":"A504","pred":"tao:has_database_id","subj":"504","obj":"Tax:9606"},{"id":"A507","pred":"tao:has_database_id","subj":"507","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]."}